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Background
cGMP is an important second messenger which is
involved in the regulation of cardiac contractility and
pathological hypertrophy. Signaling by cGMP is consid-
ered cardioprotective, but little is known about the spa-
tio-temporal dynamics of cGMP and its regulation in
adult cardiomyocytes.
Materials and methods
We generated a transgenic mouse model with cardio-
myocyte-specific expression of the highly sensitive fluor-
escence resonance energy transfer (FRET)-based cGMP
biosensor red cGES-DE5. This sensor mouse allows us to
performed FRET measurements of cGMP in freshly iso-
lated adult mouse ventricular myocytes, to visulaize real-
time dynamics of cGMP. To analyze cAMP and cGMP
interactions (cGMP/cAMP signaling crosstalk), FRET
experiments were performed in cardiomyocytes isolated
from mice, transgenically expressing the FRET-based
cAMP sensor Epac1-camps.
Results
In adult mouse cardiac myocytes, cytosolic cGMP levels
are low (~10 nM), but can be markedly increased by sti-
mulation of particulate guanylyl cyclases (GC-A, GC-B)
with natriuretic peptides (CNP>>ANP/BNP). In contrast,
stimulation of the soluble guanylyl cyclase (sGC) with
NO-donors such as SNAP had no effect. However, consti-
tutive activity of this cyclase is involved in basal cGMP
production, since stimulating cardiomyocytes with the
sGC inhibitor ODQ showed a decrease of basal cGMP
levels. This basal cGMP production is balanced by phos-
phodiesterase (PDE) activity. Inhibiting PDE1,2 and 5 had
only little effect, whereas PDE3 represents the major
cGMP-PDE family controlling cGMP levels at basal state,
in the presence of cGMP agonists (such as SNAP, ANP,
and CNP) and in a model of cardiac hypertrophy (trans-
verse aortic constriction model). In addition we could
show that cGMP pools produced by GC-B after CNP sti-
mulation are mainly regulated by PDE3, so that the recep-
tor and this PDE form one functional unit important for
the regulation of cGMP/cAMP cross-talk and modulation
of cAMP levels.
Conclusion
We conclude that PDE3 is the dominant PDE regulating
cGMP.
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